It was announced Thursday that IMS Health (RX) was to be stolen from its shareholders for $4 billion or about $22 share; a private equity firm will buy them out. IMS Health should have free cash flows ...

NORWALK, Conn.--(BUSINESS WIRE)--Global prescription sales growth of generics drugs slowed to 3.6 percent in the twelve months ending September 2008, down from 11.4 percent in 2007, according to a new ...

The UK Competition Commission has provisionally decided not to remove or vary current restrictions on how IMS Health sells its specialised pharmaceutical data services. The UK Competition Commission ...

PARSIPPANY, N.J. — U.S. spending on drugs grew 2.3% to $307.4 billion in 2010, according to a new report by the IMS Institute for Healthcare Informatics, part of industry research firm IMS Health. The ...